| Richard J. Faleschini |
President and Chief Executive Officer
Before joining BioSphere Medical, Mr. Faleschini served as the Vice President
and General Manager of the gynecology division of American Medical Systems. Mr. Faleschini
joined AMS in November 1999 as the Vice President of Marketing and Sales and served
in that position until he assumed his general management responsibilities in 2003.
Prior to AMS, Mr. Faleschini held executive marketing and general management positions at Medtronic
with responsibilities in several sectors of their cardiac rhythm management, cardiac surgery,
and interventional vascular businesses from 1995 to 1999. His previous experience
also includes executive marketing and sales management responsibilities at Cordis
Corporation (1990-1995), Biomagnetic Technologies (1985-1990), and ATL/ADR Ultrasound (1977-1985).
In addition he has also assisted in raising capital through venture financings and initial
and secondary public offerings. Mr. Faleschini received his B.S. in biology and M.S. in physiology
from Michigan Technological University.
|
| Martin J. Joyce |
Executive Vice President of Finance and Administration and Chief Financial Officer
Prior to joining BioSphere Medical in September 2004, Mr. Joyce served from 2000 to 2004 as
Managing Partner of Stratex Group LLC, a provider of biopharmaceutical executive
services to early-stage companies and venture investors. From 1996 to 2000,
Mr. Joyce was North American CFO for Serono Inc. From 1987 to 1996, Mr. Joyce
held a variety of senior level positions within Serono, in finance, sales, marketing
and manufacturing. Mr. Joyce's earlier years were spent at Millipore and Bose
Corporations focusing on strategic planning, product rationalization and return on
investment analysis. Mr. Joyce holds an M.B.A. from Suffolk University and an undergraduate
degree from Northeastern University.
|
| Melodie R. Domurad |
Vice President of Regulatory, Medical Affairs, and
Quality Systems
Melodie R. Domurad has served as our Vice President of Regulatory,
Medical Affairs, and Quality Systems since January 2008. From 1997 to 2007,
Ms. Domurad served as Vice President of Clinical, Regulatory, and Quality
Affairs for Matritech, Inc., a leading developer of proteomics-based diagnostic
products for the early detection of cancer. From 1994 to 1997, Ms. Domurad held
the position of Director of Clinical Research and Clinical Research Manager at
Ergo Science, Inc., where she focused on therapeutics for diabetes, obesity, and
cancer. Prior to joining Ergo Science Inc., Ms. Domurad held leadership roles
at the Center for the Study of Nutrition and Medicine at the New England
Deaconess Hospital, and the Cambridge Center for Holistic Health. Ms. Domurad
holds a B.A. from Cornell University and a Ph.D. from the University of
Cincinnati.
|
| Willard W. Hennemann |
Vice President of New Product and
Business Development
Willard W. Hennemann was named our Vice President of New Product and
Business Development in February 2008. From 2006 to early 2008, Dr. Hennemann
served as Vice President of Intravascular Systems/Marketing for Medeikon
Corporation, an early-stage developer of proprietary disposable technologies
to treat cardiovascular disease. From 2000 to 2006, Dr. Hennemann held the
position of Vice President of Research and Development/Interventional Vascular
at CryoCath Technologies, a world leader in catheter-based products for the
cryotherapeutic treatment of cardiovascular disease. From 1998 to 1999, Dr.
Hennemann served as Director of Marketing and Product Development for
Intervascular (a division of Datascope), which produces a broad line of vascular
grafts. From 1996 to 1998, Dr. Hennemann served as Director of
Marketing/International Clinical Studies of the Global Stent Business Unit for
Medtronic, Inc., the world leader in various forms of medical technology.
Prior to Medtronic, Dr. Hennemann assumed roles of increasing responsibility
over a 12-year period with Cordis Corporation, a pioneer in developing
innovative diagnostic and therapeutic devices for interventional vascular
medicine. Dr. Hennemann received his B.A. from the University of Maryland and
a Ph.D. from the University of Florida.
|
| Peter Sutcliffe |
Vice President of Manufacturing
Mr. Sutcliffe has served as Vice President, Manufacturing since October 2002.
Mr. Sutcliffe served as the Vice President for North American Manufacturing for Whatman, Plc.,
a life science filtration company, from May 2001 until October 2002. From May 1996 to May 2001,
he was the Chief Operating Officer for HemaSure, Inc., a manufacturer and supplier of blood filters.
From May 1982 until May 1996, Mr. Sutcliffe held the position of Vice President of Manufacturing for
Corning Costar Company, a life science products company. Prior to Costar, he held manufacturing management
positions with Millipore, a high technology bioscience company from October 1976 until May 1982.
Mr. Sutcliffe holds a B.S. in biology from the University of Richmond in Virginia and an M.B.A.
from Sul Ross State University of Texas, Fort Bliss, Texas. |
| Joel B. Weinstein |
Vice President of Global Marketing and
Sales
Joel B. Weinstein has served as our Vice President of Global Marketing and
Sales since January 2008. Prior to joining Biosphere Medical, Mr. Weinstein
founded and led several medical device companies, and founded his own firm,
which provided strategic counsel to medical device companies and venture capital
firms. From 1987 to 1998, Mr. Weinstein served as Vice President of Marketing
and Business Development for Hologic, Inc., one of the world’s largest medical
device companies focused on women’s health. Prior to Hologic, Mr. Weinstein had
progressively greater management responsibilities over a seven year period with
Advanced Technology Laboratories, one of the world’s leading multi-modality
diagnostic ultrasound companies. He received his bachelor’s degree in Electrical
Engineering from City College of New York and an MBA from Western New England
College.
|
Board of Directors
Richard J. Faleschini
President and Chief Executive Officer
BioSphere Medical, Inc.
William M. Cousins, Jr.
President
William M Cousins, Jr., Inc.
Timothy J. Barberich
Executive Chairman
Sepracor, Inc.
David P. Southwell
Executive Vice President and Chief Financial Officer
Sepracor, Inc.
Alexander M. Klibanov, Ph.D.
Professor of Chemistry
Massachusetts Institute of Technology
Riccardo Pigliucci
Management Consultant
Jack Mackinnon
Partner (Retired)
Pricewaterhouse Coopers
Marian L. Heard
President and Chief Executive Officer
Oxen Hill Partners
Officers
Richard J. Faleschini
President and Chief Executive
Martin J. Joyce
Chief Financial Officer
Melodie R. Domurad
Vice President
Regulatory, Medical Affairs, and Quality Systems
Willard W. Hennemann
Vice President
New Product and Business Development
Peter Sutcliffe
Vice President
Manufacturing
Joel B. Weinstein
Vice President
Global Marketing and Sales
|
 |
